LIVN Insider Trading

Insider Ownership Percentage: 0.27%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $3,467,346.03

LivaNova Insider Trading History Chart

This chart shows the insider buying and selling history at LivaNova by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$2M$0$2MTotal Insider BuyingTotal Insider Selling

LivaNova Share Price & Price History

Current Price: $39.13
Price Change: Price Decrease of -0.49 (-1.24%)
As of 03/28/2025 05:00 PM ET

This chart shows the closing price history over time for LIVN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$39.13Closing price on 03/29/25:

LivaNova Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for LivaNova (NASDAQ:LIVN)

97.64% of LivaNova stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LIVN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$241Mbought$112MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200M-$100M$0$100M$200MTotal InflowsTotal Outflows
LivaNova logo
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Read More on LivaNova

Today's Range

Now: $39.13
Low: $39.03
High: $39.63

50 Day Range

MA: $44.51
Low: $37.02
High: $50.73

52 Week Range

Now: $39.13
Low: $36.85
High: $64.48

Volume

320,232 shs

Average Volume

609,833 shs

Market Capitalization

$2.13 billion

P/E Ratio

93.17

Dividend Yield

N/A

Beta

1.1

Who are the company insiders with the largest holdings of LivaNova?

LivaNova's top insider investors include:
  1. Damien Mcdonald (CEO)
  2. Daniel Jeffrey Moore (Director)
  3. Francesco Bianchi (Director)
Learn More about top insider investors at LivaNova.

Who are the major institutional investors of LivaNova?

LivaNova's top institutional shareholders include:
  1. Primecap Management Co. CA — 8.76%
  2. Vanguard Group Inc. — 4.33%
  3. Capital Research Global Investors — 2.97%
  4. Geode Capital Management LLC — 2.46%
  5. Dimensional Fund Advisors LP — 2.41%
  6. Ameriprise Financial Inc. — 1.93%
Learn More about top institutional investors of LivaNova stock.

Which major investors are selling LivaNova stock?

Within the last quarter, LIVN stock was sold by these institutional investors:
  1. Point72 Asset Management L.P.
  2. Primecap Management Co. CA
  3. Magnetar Financial LLC
  4. ExodusPoint Capital Management LP
  5. Bank of America Corp DE
  6. Bank of Montreal Can
  7. Emerald Mutual Fund Advisers Trust
  8. Twinbeech Capital LP
During the last year, company insiders that have sold LivaNova company stock include:
  1. Damien Mcdonald (CEO)
  2. Daniel Jeffrey Moore (Director)
Learn More investors selling LivaNova stock.

Which major investors are buying LivaNova stock?

Within the last quarter, LIVN stock was purchased by institutional investors including:
  1. Freestone Grove Partners LP
  2. Artisan Partners Limited Partnership
  3. The Manufacturers Life Insurance Company
  4. AQR Capital Management LLC
  5. Vanguard Group Inc.
  6. Capital Research Global Investors
  7. Marshall Wace LLP
  8. Raymond James Financial Inc.